Advertisement

Topics

Genzyme Company Profile

05:27 EDT 23rd September 2017 | BioPortfolio

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases. Since its founding in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2006 revenues of $3.2 billion. Over the past two decades Genzyme has introduced a number of breakthrough treatments in several areas of medicine, which have provided hope to patients who previously had no viable treatment options. Genzyme products are helping patients in nearly 90 countries. Today, Genzyme continues to be driven by its commitment to patients. The company is working to develop new medicines, improve its existing therapies, secure approvals for its products around the world, and ensure that patients have access to these treatments. Genzyme, which has its headquarters in Cambridge, Massachusetts, was selected by FORTUNE as one of the “100 Best Companies to Work for” in the United States in 2006 and 2007.

Location

500 Kendall Street
Cambridge
MA
02142
United States of America

Contact

Phone: 617 252 7500
Fax: 617 252 7600


News Articles [66 Associated News Articles listed on BioPortfolio]

STAT Plus: New chief aims to remake Sanofi Genzyme

Sanofi Genzyme's new president, Bill Sibold, is the first one without any ties to the old Genzyme, which pioneered the rare-disease business model.

Family, friends recall contributions of former Genzyme executive Henri Termeer

Hundreds gathered on the MIT campus Saturday morning to celebrate the life of Henri Termeer, the former Genzyme Corp. chief executive who oversaw the company's growth from a small local firm to a ...

Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer

Henri Termeer, a biotechnology pioneer and the longtime CEO of Genzyme, has passed away at the age of 71. According to the Boston Globe, Termeer collapsed in his home in Marblehead, MA, on Friday nigh...

Sanofi Genzyme Reports Results From Phase 2 Open-Label Extension Study

PARIS (dpa-AFX) - Sanofi Genzyme, the specialty care global business unit of Sanofi (SNYNF), and Alnylam Pharmaceuticals, Inc announced new positive results from the ongoing phase 2 open-label ext...

Alnylam and Sanofi Genzyme to Present New Clinical Trial Results at the International Society of Thrombosis and Haemostasis (ISTH) Congress

Monday, June 26th 2017 at 8:01pm UTC – New Data from an Ongoing Phase 2 Open-label Extension Study with Fitusiran in Patients with Hemophilia A and B, With or Without Inhibitors– CAMBRIDGE, Mass.&...

Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 01052017] Prices from USD $350

Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sanofi Genzyme Mergers Acquisitions MA, Partnerships Alliances and Investments report inclu...

Biotech loses pioneer Henri Termeer

Friday, May 12th, Genzyme founder Henri Termeer passed at age 71. Termeer led Genzyme of almost 30 years. He rose to CEO shortly before its acquisition by Sanofi in 2011. Many in the industry credit T...

Alnylam and Sanofi Genzyme Initiate Phase 3 Program of Investigational RNAi Therapeutic Fitusiran

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Sanofi Genzyme, the specialty care global business unit of Sano...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Cerezyme [Genzyme Corporation]

Thyrogen [Genzyme Corporation]

Renagel [Genzyme Corporation]

These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use In...

Aldurazyme [Genzyme Corporation]

These highlights do not include all the information needed to use ALDURAZYME safely and effectively. See full prescribing information for ALDURAZYME. ALDURAZYME (laronidase)Solution for intravenous in...

Carticel [Genzyme Corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel® (autologous cultured chondrocytes) For Auto...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Low-Dose Anti-Thymocyte Globulin for Graft-Versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplant.

Graft-versus-host disease (GVHD) is a leading cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (alloHCT). Prophylactic in-vivo T-Cell depletion with antithymocyte...

Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.

Deficiency of glucocerebrosidase (GBA) causes Gaucher disease (GD). In the common non-neuronopathic GD type I variant, glucosylceramide accumulates primarily in the lysosomes of visceral macrophages. ...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approve...

Extension Study of Long-Term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

This extension study was to monitor the long-term safety and efficacy of rhGAA treatment in a single patient with infantile-onset Pompe disease who were previously treated with rhGAA in a ...

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

This open-label, rater-blinded extension study will enroll patients who have relapsing-remitting multiple sclerosis (RRMS) and who participated in one of three prior Genzyme-sponsored stud...

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

This study is sponsored by Genzyme Japan K.K. The purpose of this study is to assess the safety, tolerability and pharmacokinetics of Clofarabine (JC0707) intravenously administered to Jap...

Comparison of ATG to Thymoglobuline in Renal Transplantation

An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Freseni...

Companies [20 Associated Companies listed on BioPortfolio]

Genzyme

Genzyme is one of the world’s leading biotechnology companies. Its more than 9,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact o...

Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals t...

Genzyme Corp.

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company ha...

Genzyme Genetics

Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services. As a business unit of Genzyme Corporation, Genzyme Genetics em...

Sanofi Genzyme

More Information about "Genzyme" on BioPortfolio

We have published hundreds of Genzyme news stories on BioPortfolio along with dozens of Genzyme Clinical Trials and PubMed Articles about Genzyme for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genzyme Companies in our database. You can also find out about relevant Genzyme Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record